ANGEL MEDICAL CENTER
Franklin, NC · CCN 341326 · Rates published
885,263 of 1,516,673 rate rows are consumer-grade (58.4%)
631,410 rows are marked excluded from the consumer medians — these stay visible in the raw drill-down with the same reason shown here, so nothing is silently hidden.
| Excluded — reason | Rows |
|---|---|
| no usable negotiated amount (only an out-of-band fallback) — excluded from medians | 590,035 |
| percent-of-billed methodology on a DRG bundle — not comparable to case rates; shown as context only | 33,741 |
| below 25% of the Medicare reference for this DRG — likely a mislabeled per-diem; excluded from rankings | 3,835 |
| per-diem day rate — not a per-procedure price | 3,580 |
| placeholder amount (≤ $0.02) — excluded from medians | 123 |
| below 25% of the Medicare reference for this code — likely a mislabeled per-diem or placeholder; excluded from medians | 82 |
| exceeds 10× this hospital's gross charge — excluded from medians | 14 |
| Source MRF file | https://www.hcadam.com/api/public/content/4e8c79acd9774072b8f4cec67eb8b2bb?download=true |
|---|---|
| Found on page | https://www.missionhealth.org/patient-resources/patient-financial-resources/pricing-transparency-cms-required-file-of-standard-charges |
| Discovered via | Discovered by HANK |
| Last fetch | Latest re-check couldn't be parsed — showing last good data · 2026-08-04 |
| Content fingerprint | 71e664703840cb80… · 548,074,736 bytes · first seen 2026-05-05 |
Top 50 most expensive offerings
Outliers are flagged where this hospital's filed rate is ≥2× or ≤0.5× the national median for the same code.
| Code | Description | Payers | Min $ | Max $ | Avg median | vs national |
|---|---|---|---|---|---|---|
|
9138 OTHER |
Inj, Hemgenix, Per Tx Dos | 1 | $4,407,480.00 | $4,422,320.40 | $4,414,900.20 |
nat. median $3,758,972 1.2× median |
|
773 OTHER |
Inj, Beqvez, Per Tx Dose | 1 | $4,326,000.00 | $4,326,000.00 | $4,326,000.00 |
nat. median $3,646,097 1.2× median |
|
908 OTHER |
Topi Adm Prad Zami Per Tr | 1 | $4,002,984.00 | $4,002,984.00 | $4,002,984.00 |
nat. median $29,683 outlier · 134.9× |
|
714 OTHER |
Inj Delandistrogene Mox R | 1 | $3,990,546.00 | $3,993,432.00 | $3,991,989.00 |
nat. median $3,325,455 1.2× median |
|
748 OTHER |
Inj, Lovotibeglogene Auto | 1 | $3,903,009.60 | $3,943,200.00 | $3,923,104.80 |
nat. median $3,252,508 1.2× median |
|
906 OTHER |
Inj Elivaldogene Autoteme | 1 | $3,816,000.00 | $3,816,000.00 | $3,816,000.00 |
nat. median $24,604 outlier · 155.1× |
|
746 OTHER |
Inj, Betibeglogene Autote | 1 | $3,527,962.80 | $3,561,600.00 | $3,544,781.40 |
nat. median $2,939,969 1.2× median |
|
9141 OTHER |
Inj Onase Abepar-xioi Tre | 2 | $2,866,336.80 | $4,299,505.20 | $3,106,777.20 |
nat. median $2,588,981 1.2× median |
|
824 OTHER |
Inj, Exagamglogene Autote | 1 | $2,798,400.00 | $2,798,400.00 | $2,798,400.00 |
nat. median $58,186 outlier · 48.1× |
|
J3399 HCPCS |
Injection, Onasemnogene Abeparvovec-xioi, Per Treatment, Up To 5x10°15 Vector Ge… | 1 | $2,125,000.00 | $2,125,000.00 | $2,125,000.00 |
nat. median $2,460,273 0.9× median |
|
Q2042 HCPCS |
Tisagenlecleucel, Up To 600 Million Car-positive Viable T Cells, Including Leuka… | 1 | $1,369,371.65 | $1,369,371.65 | $1,369,371.65 |
nat. median $691,418 2.0× median |
|
Q2056 HCPCS |
Ciltacabtagene Autoleucel, Up To 100 Million Autologous B-cell Maturation Antige… | 1 | $1,328,128.35 | $1,328,128.35 | $1,328,128.35 |
nat. median $631,793 outlier · 2.1× |
|
Q2041 HCPCS |
Axicabtagene Ciloleucel, Up To 200 Million Autologous Anti-cd19 Car Positive Via… | 1 | $1,279,600.63 | $1,279,600.63 | $1,279,600.63 |
nat. median $588,565 outlier · 2.2× |
|
Q2053 HCPCS |
Brexucabtagene Autoleucel, Up To 200 Million Autologous Anti-cd19 Car Positive V… | 2 | $373,000.00 | $1,175,752.00 | $1,175,752.00 |
nat. median $577,541 outlier · 2.0× |
|
2067 OTHER |
Afamitresgene Autoleucel | 1 | $924,744.00 | $924,744.00 | $924,744.00 |
nat. median $786,032 1.2× median |
|
9498 OTHER |
Ciltacabtagene Car-pos T | 2 | $632,548.08 | $948,822.12 | $705,179.52 |
nat. median $587,650 1.2× median |
|
9194 OTHER |
Tisagenlecleucel Car-pos | 2 | $635,031.48 | $952,547.22 | $679,837.56 |
nat. median $576,820 1.2× median |
|
9413 OTHER |
Lisocabtagene Car Pos T | 2 | $620,071.32 | $930,106.98 | $674,641.44 |
nat. median $562,201 1.2× median |
|
9422 OTHER |
Idecabtagene Vicleucel Ca | 2 | $631,905.12 | $947,857.68 | $669,698.16 |
nat. median $560,872 1.2× median |
|
9035 OTHER |
Axicabtagene Ciloleucel C | 2 | $587,347.20 | $881,020.80 | $638,630.64 |
nat. median $533,230 1.2× median |
|
9391 OTHER |
Brexucabtagene Car Pos T | 2 | $552,636.48 | $828,954.72 | $587,340.24 |
nat. median $492,768 1.2× median |
|
831 OTHER |
Obecbtge Autol Up To 400 | 1 | $333,900.00 | $333,900.00 | $333,900.00 |
nat. median $20,175 outlier · 16.6× |
|
897 OTHER |
Revakinagene, Per Implant | 1 | $318,000.00 | $318,000.00 | $318,000.00 |
nat. median $19,528 outlier · 16.3× |
|
886 OTHER |
Inj. Remestemcel-l-rknd/ | 1 | $242,002.80 | $242,002.80 | $242,002.80 |
nat. median $200,661 1.2× median |
|
1907 OTHER |
New Technology - Level 52 | 2 | $183,000.60 | $274,500.90 | $191,257.56 |
nat. median $155,877 1.2× median |
|
1908 OTHER |
New Technology - Level 52 | 2 | $183,000.60 | $274,500.90 | $191,257.56 |
nat. median $155,877 1.2× median |
|
1906 OTHER |
New Technology - Level 51 | 2 | $165,000.60 | $247,500.90 | $172,445.40 |
nat. median $140,545 1.2× median |
|
1905 OTHER |
New Technology - Level 51 | 2 | $165,000.60 | $247,500.90 | $172,445.40 |
nat. median $140,545 1.2× median |
|
J9029 HCPCS |
Intravesical Instillation, Nadofaragene Firadenovec-vncg, Per Therapeutic Dose | 1 | $166,116.65 | $166,116.65 | $166,116.65 |
nat. median $69,291 outlier · 2.4× |
|
516430 CDM |
Kit Implnt Hrtmt 3 Kit | 17 | $68,849.21 | $364,495.82 | $158,069.68 |
nat. median $162,274 1.0× median |
|
1904 OTHER |
New Technology - Level 50 | 2 | $147,000.60 | $220,500.90 | $153,633.24 |
nat. median $122,500 1.3× median |
|
1903 OTHER |
New Technology - Level 50 | 2 | $147,000.60 | $220,500.90 | $153,633.24 |
nat. median $122,500 1.3× median |
|
Q2043 HCPCS |
Sipuleucel-t, Minimum Of 50 Million Autologous Cd54+ Cells Activated With Pap-gm… | 2 | $51,363.25 | $145,223.54 | $145,223.54 |
nat. median $65,655 outlier · 2.2× |
|
456896 CDM |
Device Vntrc Asst Hrtmt | 17 | $59,931.29 | $317,283.30 | $137,595.19 |
nat. median $66,206 outlier · 2.1× |
|
1901 OTHER |
New Technology - Level 49 | 2 | $129,000.60 | $193,500.90 | $134,821.08 |
nat. median $107,500 1.3× median |
|
1902 OTHER |
New Technology - Level 49 | 2 | $129,000.60 | $193,500.90 | $134,821.08 |
nat. median $107,500 1.3× median |
|
494847 CDM |
Syst Imp Hrtmt2 Lft Vent | 17 | $56,489.73 | $299,063.26 | $129,693.76 |
nat. median $132,044 1.0× median |
|
C9293 HCPCS |
Glucarpidase 1000 U Inj | 16 | $52,309.71 | $276,933.76 | $120,004.63 |
nat. median $24,377 outlier · 4.9× |
|
1599 OTHER |
New Technology - Level 48 | 2 | $114,000.60 | $171,000.90 | $119,144.30 |
nat. median $97,104 1.2× median |
|
1585 OTHER |
New Technology - Level 48 | 2 | $114,000.60 | $171,000.90 | $119,144.30 |
nat. median $97,104 1.2× median |
|
J9999 HCPCS |
Carmustine Wafers 8/box | 16 | $51,915.48 | $274,846.66 | $119,100.22 |
nat. median $2,547 outlier · 46.8× |
|
J9226 HCPCS |
Histrelin Implant (supprelin La), 50 Mg | 2 | $41,773.13 | $110,645.59 | $110,645.59 |
nat. median $55,200 outlier · 2.0× |
|
1584 OTHER |
New Technology - Level 47 | 2 | $102,000.60 | $153,000.90 | $106,602.86 |
nat. median $86,882 1.2× median |
|
1598 OTHER |
New Technology - Level 47 | 2 | $102,000.60 | $153,000.90 | $106,602.86 |
nat. median $86,882 1.2× median |
|
1597 OTHER |
New Technology - Level 46 | 2 | $90,000.60 | $135,000.90 | $94,061.42 |
nat. median $76,661 1.2× median |
|
1583 OTHER |
New Technology - Level 46 | 2 | $90,000.60 | $135,000.90 | $94,061.42 |
nat. median $76,661 1.2× median |
|
1596 OTHER |
New Technology - Level 45 | 2 | $78,000.60 | $117,000.90 | $81,519.98 |
nat. median $66,440 1.2× median |
|
1582 OTHER |
New Technology - Level 45 | 2 | $78,000.60 | $117,000.90 | $81,519.98 |
nat. median $66,440 1.2× median |
|
5244 OTHER |
Level 4 Blood Product Exc | 2 | $62,479.40 | $93,719.11 | $80,595.71 |
nat. median $64,263 1.3× median |
|
1643 OTHER |
Y90 Ibritumomab, Rx | 2 | $68,189.46 | $117,857.84 | $78,571.90 |
nat. median $60,802 1.3× median |
Other procedures at this hospital
Browse this hospital's 28,762 published procedures. Use the slice to choose what to show, then sort or filter any column.